Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease

被引:30
作者
Kan, Hiromi [1 ]
Kimura, Yuki [3 ]
Hyogo, Hideyuki [1 ]
Fukuhara, Takayuki [1 ]
Fujino, Hatsue [1 ]
Naeshiro, Noriaki [1 ]
Honda, Yohji [1 ]
Kawaoka, Tomokazu [1 ]
Tsuge, Masataka [1 ]
Hiramatsu, Akira [1 ]
Imamura, Michio [1 ]
Kawakami, Yoshiiku [1 ]
Aikata, Hiroshi [1 ]
Ochi, Hidenori [1 ]
Arihiro, Koji [2 ]
Chayama, Kazuaki [1 ]
机构
[1] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima 7348551, Japan
[3] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Preven, Hiroshima, Japan
关键词
liver to spleen ratio; non-alcoholic fatty liver disease; non-invasive assessment; steatotic grade; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; STEATOHEPATITIS; PREVALENCE; UTILITY; DONORS; COMMON; CT;
D O I
10.1111/hepr.12330
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThe diagnosis of non-alcoholic fatty liver disease (NAFLD) is based on the histological findings. Further, there may be interobserver differences. Liver to spleen (L/S) ratio on computed tomography (CT) is employed to detect or even quantify the fat content of the liver. The objective of this study was to accurately diagnose fatty liver by evaluating the relationship between L/S ratio and histological findings. MethodsSixty-seven biopsy-proven NAFLD patients were enrolled. L/S ratio on CT was calculated. The area of steatosis in liver specimens was measured by BIOREVO BZ-9000 microscope, and the percentage of steatosis was calculated using Dynamic cell count BZ-H1C software. ResultsSteatotic grade assessed by pathologist was significantly correlated with the percentage of steatosis and L/S ratio. Factors associated with steatosis were L/S ratio, aspartate aminotransferase and Homeostasis Model of Assessment - Insulin Resistance as determined by multivariate analysis. L/S ratios were: S0, 1.160.20 (mean +/- standard deviation); S1, 0.88 +/- 0.28; S2, 0.76 +/- 0.20; and S3, 0.40 +/- 0.18, respectively. The optimal cut-off value of L/S ratio to exclude steatosis was 1.1, and the area under the receiver-operator curve for the diagnosis of steatosis was 0.886. ConclusionOur study suggests that while 0% of steatosis showed 1.296 L/S ratio, the cut-off value of L/S ratio would be 1.1 at least to exclude clinically important liver steatosis.
引用
收藏
页码:E420 / E427
页数:8
相关论文
共 29 条
[1]   How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? [J].
Amarapurkar, Deepak N. ;
Hashimoto, Estsuko ;
Lesmana, Laurentius A. ;
Sollano, Jose D. ;
Chen, Pei-Jer ;
Goh, Khean-Lee .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) :788-793
[2]  
Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
[3]  
Charatcharoenwitthaya Phunchai, 2007, Clin Liver Dis, V11, P37, DOI 10.1016/j.cld.2007.02.014
[4]   Long term prognosis of fatty liver: risk of chronic liver disease and death [J].
Dam-Larsen, S ;
Franzmann, M ;
Andersen, IB ;
Christoffersen, P ;
Jensen, LB ;
Sorensen, TIA ;
Becker, U ;
Bendtsen, F .
GUT, 2004, 53 (05) :750-755
[5]   Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study [J].
Eguchi, Yuichiro ;
Hyogo, Hideyuki ;
Ono, Masafumi ;
Mizuta, Toshihiko ;
Ono, Naofumi ;
Fujimoto, Kazuma ;
Chayama, Kazuaki ;
Saibara, Toshiji .
JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) :586-595
[6]   Nonalcoholic fatty liver disease: From steatosis to cirrhosis [J].
Farrell, GC ;
Larter, CZ .
HEPATOLOGY, 2006, 43 (02) :S99-S112
[7]   Extremely Marginal Liver Grafts From Deceased Donors Have Outcome Similar to Ideal Grafts [J].
Goldaracena, N. ;
Quinonez, E. ;
Mendez, P. ;
Anders, M. ;
Orozco Ganem, F. ;
Mastai, R. ;
McCormack, L. .
TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) :2219-2222
[8]   The metabolic syndrome as a predictor of nonalcoholic fatty liver disease [J].
Hamaguchi, M ;
Kojima, T ;
Takeda, N ;
Nakagawa, T ;
Taniguchi, H ;
Fujii, K ;
Omatsu, T ;
Nakajima, T ;
Sarui, H ;
Shimazaki, M ;
Kato, T ;
Okuda, J ;
Ida, K .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) :722-728
[9]   Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis [J].
Hyogo, Hideyuki ;
Yamagishi, Sho-ichi ;
Iwamoto, Keiko ;
Arihiro, Koji ;
Takeuchi, Masayoshi ;
Sato, Takashi ;
Ochi, Hidenori ;
Nonaka, Michihiro ;
Nabeshima, Yoshitaka ;
Inoue, Motoki ;
Ishitobi, Tomokazu ;
Chayama, Kazuaki ;
Tazuma, Susumu .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (07) :1112-1119
[10]   Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells [J].
Iwamoto, Keiko ;
Kanno, Keishi ;
Hyogo, Hideyuki ;
Yamagishi, Sho-Ichi ;
Takeuch, Masayoshi ;
Tazuma, Susumu ;
Chayama, Kazuaki .
JOURNAL OF GASTROENTEROLOGY, 2008, 43 (04) :298-304